Securities code: 002294 securities abbreviation: Shenzhen Salubris Pharmaceuticals Co.Ltd(002294) No.: 2022-001
Shenzhen Salubris Pharmaceuticals Co.Ltd(002294)
Announcement on resolutions of the 24th Meeting of the 5th board of directors
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without falsehood
False records, misleading statements or material omissions.
The 24th Meeting of the 5th board of directors of Shenzhen Salubris Pharmaceuticals Co.Ltd(002294) (hereinafter referred to as “the company”) was held in writing on December 30, 2021, and the meeting notice was delivered by e-mail on December 27, 2021. There are 9 directors who should participate in the meeting, and 9 directors who actually participate in the meeting in written form. The number of directors present meets the quorum. The meeting was held in accordance with the company law, the articles of association and other relevant provisions.
The directors present at the meeting deliberated and formed the following resolutions:
1、 At the meeting, 9 people agreed, 0 opposed and 0 abstained, and the proposal on appointing Ms. Kong Yun as the financial director was deliberated and adopted.
Ms. Liu Jun, the financial director of the company, officially retired from the company due to her age and applied to resign as the financial director of the company. After the resignation takes effect, he will no longer hold any position in the company. According to the guidelines for the standardized operation of listed companies of Shenzhen Stock Exchange and the articles of association, Ms. Liu Jun’s resignation report shall take effect when it is delivered to the board of directors.
Upon the nomination of the general manager and the review of the nomination committee of the board of directors, it is agreed to appoint Ms. Kong Yun as the financial director. The term of office is the same as that of the Fifth Board of directors and takes effect from the date of deliberation and approval by the board of directors. At the same time, it is agreed that the financial director of the company shall receive salary according to the company’s salary regulations according to his specific management positions in the company.
In the 5th board of directors of the company, the total number of directors concurrently holding senior management positions did not exceed 1 / 2 of the total number of directors of the company. The board of directors does not have a director held by an employee representative.
The independent directors expressed the following opinions on the proposal:
After reviewing Ms. Kong Yun’s resume and other materials, it is not found that she is not allowed to serve as a senior manager of the company as stipulated in Article 146 of the company law and article 3.2.3 of the guidelines for the standardized operation of listed companies of Shenzhen Stock Exchange, nor is she confirmed as a market prohibited person by the CSRC and the prohibition has not been lifted; He / she meets the qualifications and qualifications of senior managers as stipulated in the company law and the articles of association, and is competent for the duties of the post he / she is employed. The nomination and appointment procedures of the board of directors comply with the company law, the articles of association and other relevant provisions, and are legal and effective. We agree to appoint Ms. Kong Yun as the financial director. At the same time, it is agreed that the financial director of the company shall receive salary according to the company’s salary regulations according to his specific management positions in the company.
(for the announcement on changing the financial principal, see the information disclosure media: China Securities Journal, securities times and http://www.cn.info.com.. CN.);
See the information disclosure media: http://www.cninfo.com.cn for the independent opinions of independent directors on relevant matters of the company info. com.. cn.。）
During her tenure, Ms. Liu Jun was diligent and conscientious. The company sincerely thanks Ms. Liu Jun for her contributions during her tenure!
2、 At the meeting, 9 people agreed, 0 opposed and 0 abstained, and the proposal on the provision for asset impairment was considered and adopted.
The board of Directors believes that the provision for asset impairment this time complies with the accounting standards for business enterprises, the guidelines for the standardized operation of listed companies of Shenzhen Stock Exchange and the relevant accounting policies of the company, and the basis for the provision for asset impairment is sufficient and reasonable. The accrued financial statements can more objectively and fairly reflect the company’s financial status and operating results, which is reasonable. The board of directors agrees that the company shall withdraw the provision for asset impairment in accordance with the relevant provisions of the accounting standards for business enterprises.
The independent directors expressed the following opinions on the proposal:
The company’s provision for asset impairment this time follows the principle of prudence and complies with the relevant provisions of the accounting standards for business enterprises and the actual situation of the company’s assets. The accrued financial statements can more objectively and fairly reflect the company’s asset status and operating results, and there is no damage to the legitimate rights and interests of the company and all shareholders, especially small and medium-sized shareholders. Necessary procedures have been implemented for this decision, and relevant approval and decision-making procedures are legal and compliant. We agree that the company will withdraw the provision for asset impairment this time.
(for details of the announcement on the provision for impairment of assets, please refer to the information disclosure media: China Securities Journal, securities times and www.cn.info.com.. CN.);
See the information disclosure media: http://www.cninfo.com.cn for the independent opinions of independent directors on relevant matters of the company info. com.. cn.。）
Documents for future reference
1. Resolutions of the board of directors signed and sealed by the directors attending the meeting;
2. Other documents required by SZSE.
It is hereby announced
Shenzhen Salubris Pharmaceuticals Co.Ltd(002294) board of directors
January 4, 2002
